News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sihuan Pharmaceutical Holdings Group Ltd. Approved for China Trials of Innovative Cancer Drug


10/11/2013 11:08:51 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 11, 2013 -- Sihuan Pharma reported that the CFDA has approved its application to begin clinical trials of pirotinib, a Category 1.1 innovative drug that was developed by the company’s own R&D operation. Although Sihuan is known for its cardio-cerebral vascular products, it also produces treatments for cancer. Pirotinib is the first cancer drug that Sihuan discovered and developed itself. More details....

Stock Symbol: (HK: 0460)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES